amlotens b tablet 10mg
goldplus universal pte ltd - amlodipine besilate 13.88mg eqv amlodipine - tablet - 10mg
amlotens b tablet 5mg
goldplus universal pte ltd - amlodipine besilate 6.94mg eqv amlodipine - tablet - 5mg
amlotens tablet 10mg
goldplus universal pte ltd - amlodipine mesilate monohydrate 12.79 mg eqv amlodipine base - tablet - 10mg - amlodipine mesilate monohydrate 12.79 mg eqv amlodipine base 10 mg
amlotens tablet 5mg
goldplus universal pte ltd - amlodipine mesilate monohydrate 6.395 mg eqv amlodipine base - tablet - 5.00mg - amlodipine mesilate monohydrate 6.395 mg eqv amlodipine base 5 mg
ambotens 300 irbesartan 300 mg tablets blister pack
medis pharma pty ltd - irbesartan, quantity: 300 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; croscarmellose sodium; hypromellose; magnesium stearate; microcrystalline cellulose; mannitol; titanium dioxide; hyprolose; macrogol 400 - ambotens is indicated for the treatment of hypertension.,ambotens is indicated for delaying the progression of renal disease in hypertensive type ii diabetics with persistent micro-albuminuria (greater than or equal to 30 mg per 24 hours) or urinary protein in excess of 900 mg per 24 hours.
ambotens 75 irbesartan 75 mg tablets blister pack
medis pharma pty ltd - irbesartan, quantity: 75 mg - tablet, film coated - excipient ingredients: mannitol; colloidal anhydrous silica; croscarmellose sodium; magnesium stearate; microcrystalline cellulose; hypromellose; titanium dioxide; hyprolose; macrogol 400 - ambotens is indicated for the treatment of hypertension.,ambotens is indicated for delaying the progression of renal disease in hypertensive type ii diabetics with persistent micro-albuminuria (greater than or equal to 30 mg per 24 hours) or urinary protein in excess of 900 mg per 24 hours.
ambotens 150 irbesartan 150 mg tablets blister pack
medis pharma pty ltd - irbesartan, quantity: 150 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; croscarmellose sodium; mannitol; colloidal anhydrous silica; hypromellose; magnesium stearate; titanium dioxide; hyprolose; macrogol 400 - ambotens is indicated for the treatment of hypertension.,ambotens is indicated for delaying the progression of renal disease in hypertensive type ii diabetics with persistent micro-albuminuria (greater than or equal to 30 mg per 24 hours) or urinary protein in excess of 900 mg per 24 hours.
ambotens 150 irbesartan 150 mg tablets blister pack
medis pharma pty ltd - irbesartan, quantity: 150 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; croscarmellose sodium; mannitol; colloidal anhydrous silica; hypromellose; magnesium stearate; titanium dioxide; hyprolose; macrogol 6000 - ambotens is indicated for the treatment of hypertension.,ambotens is indicated for delaying the progression of renal disease in hypertensive type ii diabetics with persistent micro-albuminuria (greater than or equal to 30 mg per 24 hours) or urinary protein in excess of 900 mg per 24 hours.
ambotens 300 irbesartan 300 mg tablets blister pack
medis pharma pty ltd - irbesartan, quantity: 300 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; croscarmellose sodium; hypromellose; magnesium stearate; microcrystalline cellulose; mannitol; titanium dioxide; hyprolose; macrogol 6000 - ambotens is indicated for the treatment of hypertension.,ambotens is indicated for delaying the progression of renal disease in hypertensive type ii diabetics with persistent micro-albuminuria (greater than or equal to 30 mg per 24 hours) or urinary protein in excess of 900 mg per 24 hours.
ambotens 75 irbesartan 75 mg tablets blister pack
medis pharma pty ltd - irbesartan, quantity: 75 mg - tablet, film coated - excipient ingredients: mannitol; colloidal anhydrous silica; croscarmellose sodium; magnesium stearate; microcrystalline cellulose; hypromellose; titanium dioxide; hyprolose; macrogol 6000 - ambotens is indicated for the treatment of hypertension.,ambotens is indicated for delaying the progression of renal disease in hypertensive type ii diabetics with persistent micro-albuminuria (greater than or equal to 30 mg per 24 hours) or urinary protein in excess of 900 mg per 24 hours.